Bio-Rad Laboratories Inc. (BIO) Misses Q1 EPS by 2c
Tweet
Share
E-mailGet Alerts BIO Hot Sheet
Price: $376.41 -1.57%
EPS Growth %: -1.3%
Financial Fact:
Research and development expense: 52.17M
Today's EPS Names:
VIVO, OCCI, ALZN, More
EPS Growth %: -1.3%
Financial Fact:
Research and development expense: 52.17M
Today's EPS Names:
VIVO, OCCI, ALZN, More
Join SI Premium – FREE
Bio-Rad Laboratories Inc. (NYSE: BIO) reported Q1 EPS of $1.09, $0.02 worse than the analyst estimate of $1.11. Revenue for the quarter came in at $486.3 million versus the consensus estimate of $492.35 million.
For earnings history and earnings-related data on Bio-Rad Laboratories Inc. (BIO) click here.
For earnings history and earnings-related data on Bio-Rad Laboratories Inc. (BIO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Westinghouse said to seek over $50 billion valuation in planned IPO
- UBS Reiterates Neutral Rating on Intuit (INTU), Says Investor Day Not 'Sentiment-Changing'
- Lumentum shares rise on analyst upgrades, AI demand outlook
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
